Tag: Ftd

Currently, no medication is approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of frontotemporal dementia (FTD). Due to the lack of approved therapies, the question 'Does memantine help frontotemporal dementia?' has been a subject of significant clinical interest and investigation, particularly since memantine is used for Alzheimer's disease.

In stark contrast to its use in Alzheimer's disease, donepezil is generally not recommended for Frontotemporal Dementia (FTD) and has been shown to potentially worsen behavioral symptoms in a subgroup of patients. The distinct underlying neuropathologies of these two forms of dementia explain why a treatment for one can be ineffective or even harmful for the other.